Showing results (131-140 of 286) with videos related to

Sort By:
Pageof 29
Cancer Medicine|November 23, 2022
MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangementsYohei Takumi, Sachiko Arai, Chiaki Suzuki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID miceHirokazu Ogino, Seiji Yano, Soji Kakiuchi, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 28, 2024
Prognostic value of coexisting conditions and complications in pleuroparenchymal fibroelastosis: a single-center retrospective studyKazuhiko Iwasaki, Satoshi Watanabe, Kazumasa Kase, et al.
International Immunopharmacology|May 31, 2024
Combining dynamics of serum inflammatory and nutritional indicators as novel biomarkers in immune checkpoint inhibitor treatment of non-small-cell lung cancer with bone metastasesYohei Asano, Katsuhiro Hayashi, Akihiko Takeuchi, et al.
Anticancer Research|September 30, 2024
Serum Inflammatory Dynamics as Novel Biomarkers for Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer With Bone MetastasesYohei Asano, Norio Yamamoto, Katsuhiro Hayashi, et al.
International Journal of Clinical Oncology|July 6, 2010
Metastatic renal cell carcinoma complicated with diffuse alveolar hemorrhage: a rare adverse effect of sunitinibTadaaki Yamada, Koushiro Ohtsubo, Kouji Izumi, et al.
The Journal of Medical Investigation : JMI|September 29, 2017
Androgen replacement therapy for cancer-related symptoms in male advanced cancer patients: study protocol for a randomised prospective trial (ARTFORM study)Kouji Izumi, Kazuyoshi Shigehara, Takahiro Nohara, et al.
Oncology Reports|July 14, 2005
Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancerYoshinori Nio, Koji Hashimoto, Seiji Yano, et al.
Clinical & Experimental Metastasis|May 14, 2010
Gender difference in bone metastasis of human small cell lung cancer, SBC-5 cells in natural killer-cell depleted severe combined immunodeficient miceSatoshi Sakaguchi, Hisatsugu Goto, Masaki Hanibuchi, et al.
Oncotarget|December 31, 2015
High efficacy of third generation EGFR inhibitor AZD9291 in a leptomeningeal carcinomatosis model with EGFR-mutant lung cancer cellsShigeki Nanjo, Hiromichi Ebi, Sachiko Arai, et al.
Pageof 29